Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
460 On Other Exchanges
460 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

sihuan pharmaceutical hldgs (460) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SIHUAN PHARMACEUTICAL HLDGS (460)

Related News

No related news articles were found.

sihuan pharmaceutical hldgs (460) Related Businessweek News

No Related Businessweek News Found

sihuan pharmaceutical hldgs (460) Details

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China. The company provides prescription drugs, including cardio-cerebral vascular drugs, anti-infective drugs, metabolism drugs, oncology drugs, and other drugs in various formulations and dosages, as well as drugs for nervous system. Further, it engages in the processing of agricultural and sideline products; provision of information support and project preparation services; promotion of technology and consulting services; construction of medical projects; and sale of medical supplies and appliances. The company distributes its products through a network of distributors and third party sales representatives to hospitals and physicians. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is headquartered in Beijing, the People’s Republic of China.

2,797 Employees
Last Reported Date: 08/11/15
Founded in 2001

sihuan pharmaceutical hldgs (460) Top Compensated Officers

Deputy Chairman, Chief Executive Officer and ...
Total Annual Compensation: CNY20.6M
Co-Founder, Executive Chairman and Member of ...
Total Annual Compensation: CNY34.6M
Deputy General Manager of Sales & Marketing a...
Total Annual Compensation: CNY13.7M
Compensation as of Fiscal Year 2014.

sihuan pharmaceutical hldgs (460) Key Developments

Sihuan Pharmaceutical Holdings Group Ltd. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Sihuan Pharmaceutical Holdings Group Ltd. reported audited consolidated earnings results for the year ended December 31, 2014. For the period, the company reported revenue of RMB 3,084,236,000 compared to RMB 2,586,402,000 for the same period a year ago. Operating profit was RMB 1,979,088,000 compared to RMB 1,497,142,000 a year ago. Profit before income tax was RMB 2,073,423,000 compared to RMB 1,602,624,000 a year ago. Profit for the year was RMB 1,684,881,000 compared to RMB 1,291,953,000 a year ago. Profit attributable to owners of the company was RMB 1,671,281,000 compared to RMB 1,284,882,000 for the same period a year ago. Basic and diluted earnings per share were RMB 16.13 compared to RMB 12.41 a year ago. Net cash generated from operating activities was RMB 1,760,936,000 compared to RMB 1,573,690,000 a year ago. Purchases of property, plant and equipment was RMB 264,080,000 compared to RMB 846,125,000 a year ago. Purchases of intangible assets were RMB 42,744,000 compared to RMB 234,498,000 a year ago.

Sihuan Pharmaceutical Holdings Group Ltd. Recommends Final Cash Dividend Final Cash Dividend for the Year Ended 31 December 2014

The Board of Sihuan Pharmaceutical Holdings Group Ltd. recommended the payment of a final cash dividend of 1.3 RMB cents per share for the year ended 31 December 2014 in return for Shareholders' support, subject to approval by the Shareholders at the forthcoming AGM. Together with an interim cash dividend of 1.3 RMB cents per share, the total cash dividend for the year ended 31 December 2014 will be 2.6 RMB cents per share.

Sihuan Pharmaceutical Holdings Group Ltd. Approves Amendments to the Articles of Association of the Company

Sihuan Pharmaceutical Holdings Group Ltd. approved amendments to the articles of association of the company, at its second extraordinary general meeting of 2015 held on July 30, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
460:HK $4.41 HKD 0.00

460 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 460.
View Industry Companies

Industry Analysis


Industry Average

Valuation 460 Industry Range
Price/Earnings 21.9x
Price/Sales 11.9x
Price/Book 3.9x
Price/Cash Flow 21.9x
TEV/Sales 10.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIHUAN PHARMACEUTICAL HLDGS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at